PPLPHARMABSEPiramal Pharma LtdLowNeutral
Announced Tue, 19 May · 14:04 IST

Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Board & Shareholder Meetings View source PDF

PPLPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.1%1-day move
₹175.95
prior close
₹172.91
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.1-0.1+0.1+0.1+0.4-0.5+1.9+1.7-1.7-6.8-9.6+1.9
Up moveDown movePending
AI summary

Piramal Pharma has disclosed the schedule of upcoming analyst and institutional investor meetings between 28th May and 12th June 2026. Five meetings are planned: 360 ONE Capital's Trinity India 2026 (28th May), Bank of America India Conference (2nd June), Citi India Conference 2026 (4th June), ICICI Securities India Investor Conference (8th June), and Goldman Sachs 2nd Annual India CRO/CDMO Tour (12th June). All meetings are group or one-on-one investor conference meetings held in Mumbai. The company notes that dates may change due to exigencies on either side.

Likely market impact

No material impact on the stock. This is a routine regulatory disclosure confirming ongoing investor engagement. The company's participation in major investor conferences signals continued focus on shareholder communication and visibility.